|
Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study |
|
|
|
Titel: |
Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study |
Auteur: |
Cheng, Ying He, Yong Li, Wei Zhang, He-long Zhou, Qing Wang, Buhai Liu, Chunling Walding, Andrew Saggese, Matilde Huang, Xiangning Fan, Minhao Wang, Jia Ramalingam, Suresh S. |
Verschenen in: |
Targeted oncology |
Paginering: |
Jaargang 16 () nr. 2 pagina's 165-176 |
Jaar: |
2021-02-05 |
Inhoud: |
|
Uitgever: |
Springer International Publishing, Cham |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|